In a world where innovative therapies are entering the market at an unprecedented pace, stakeholders need quick access to reliable information to help ensure the health care system is working as it should. They need fresh perspectives and data to keep up with how tools and techniques are working to help maintain balance in the managed care ecosystem. Enter AMCP’s recently released 2024 Access, Affordability, and Outcomes (AAO) report, which serves as a useful guide on how managed care pharmacy tools drive impact for patients.
More than 2,500 managed care pharmacy professionals from health plans, PBMs, pharmaceutical manufacturers, and other managed care organizations convened in Las Vegas, NV from Oct. 14–17 for AMCP Nexus 2024, the industry’s premier fall meeting. Attendees connected with like-minded professionals, discussed the key trends impacting their work, and expanded their perspectives through leading-edge education sessions.
Welcome to the latest update from Professional Affairs! This fall has been packed with major developments—from the release of Maximum Fair Prices for Medicare drugs to continued government focus of pharmacy benefit managers and much more.
Welcome to the first Professional Affairs blog! We plan on sharing a periodic post to recap some of the major news, journal articles, reports, and other publications from around the web that have come out since our last post. As this is our first blog, we’ll try to adequately cover the whirlwind that was July and early August 2024.
When Erica Klinger, AMCP’s Vice President of Marketing, joined the association in 2023, she met individuals who were unaware they were called “managed care pharmacists.” Now, as she tells AMCP’s Listen Up host Fred Goldstein at AMCP’s Annual Meeting in New Orleans, she is putting the community of managed care professionals in the spotlight.
AMCP recently hosted its third iteration of the IRA workshop series, bringing together health plans, pharmaceutical manufacturers, PBMs, research institutes, and patient advocacy organizations.
AMCP's Steve Kheloussi updates members of the MCP community on the newest resources for the managed care pharmacy toolbox.
With Vice President Kamala Harris likely to receive the Democratic nomination, we outline the health policy positions she has supported as a Senator, Vice President, and in her 2020 presidential campaign.
AMCP was honored to partner with The Skin of Color Society to develop two invaluable resources focusing on immune-mediated skin conditions — atopic dermatitis (AD) and alopecia areata (AA) — within the context of skin color, social determinants of health (SDOH), and health disparities. AMCP Director, Educational Programs/Grants Jennifer Evans, PharmD, BCACP, offers valuable insight into how to start bridging the gaps in care for these skin conditions in her latest blog post.
AMCP member advocates from across the country took to Capitol Hill to speak with lawmakers about ways to improve patient access to innovative new treatments as well as critical pharmacy legislation.
More than 3,500 managed care professionals from health plans, PBMs, pharmaceutical manufacturers, and other managed care organizations convened in New Orleans from April 15-18 for AMCP 2024, the industry’s largest and most impactful annual meeting. Attendees connected with like-minded professionals, discussed the important trends impacting their work, and expanded their horizons through cutting-edge education sessions.
In 2021, the AMCP Listen Up! podcast was introduced to keep health care leaders updated on the latest developments in our rapidly evolving health care system. It focuses on new pharmaceuticals, policies, payment models, and integrated delivery systems. Here are three reasons why listening to this podcast can enhance your knowledge of the managed care pharmacy landscape.